NCT06594224View on ClinicalTrials.gov

Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Pain Management
Interventions
DRUG

Ibuprofen

Patients were given 800 mg Ibuprofen in 200 cc normal saline intravenously at the time of arrival in the ward.

DRUG

Nalbuphine

Patients received 20 mg nalbuphine in 200 cc normal saline IV at the time of arrival in the ward.

Trial Locations (2)

66000

Nishtar Hospital, Multan

Nishtar Medical University, Multan

All Listed Sponsors
lead

Muhammad Aamir Latif

OTHER

NCT06594224 - Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section | Biotech Hunter | Biotech Hunter